163 results on '"Oosterhuis, Wytze P."'
Search Results
2. Awareness of drug laboratory test interactions is important for prevention of unnecessary additional diagnostics: An example
3. Waarom reflecterend testen zinvol kan zijn
4. Performance specifications and six sigma theory: Clinical chemistry and industry compared
5. Added value of drug-laboratory test interaction alerts in test result authorisation
6. ISO 15189 is a sufficient instrument to guarantee high-quality manufacture of laboratory developed tests for in-house-use conform requirements of the European In-Vitro-Diagnostics Regulation
7. The use of error and uncertainty methods in the medical laboratory
8. A survey of patients’ views from eight European countries of interpretive support from Specialists in Laboratory Medicine
9. EPMA-World Congress 2015: Bonn, Germany. 3-5 September 2015
10. Measurement uncertainty for practical use
11. Real-time monitoring of drug laboratory test interactions: a proof of concept
12. Why are clinical practice guidelines not followed?: The European Federation of Clinical Chemistry and Laboratory Medicine and European Union of Medical Specialists joint working group on Guidelines
13. European views on patients directly obtaining their laboratory test results
14. Proposal for the modification of the conventional model for establishing performance specifications
15. Laboratory medicine in the European Union
16. Bepaling van N-terminaal pro-BNP bij hartfalen: van NHG-standaard naar praktijk
17. Clinical usefulness of drug-laboratory test interaction alerts: a multicentre survey
18. The end of the laboratory developed test as we know it? Recommendations from a national multidisciplinary taskforce of laboratory specialists on the interpretation of the IVDR and its complications
19. Reflective testing – A randomized controlled trial in primary care patients
20. Critical review of laboratory investigations in clinical practice guidelines: proposals for the description of investigation
21. Real-time monitoring of drug laboratory test interactions: a proof of concept.
22. Reflective testing: adding value to laboratory testing
23. Statistical distributions commonly used in measurement uncertainty in laboratory medicine
24. α-thalassaemia masked by β gene defects and a new polyadenylation site mutation on the α2-globin gene
25. Patients with a normal exercise thallium-201 myocardial scintigram : always a good prognosis?
26. The clinical impact of thallium-201 reinjection scintigraphy for detection of myocardial viability
27. Response to Mark A. Mackay and Tony C. Badrick: on the holy grail of clinical chemistry
28. Diagnostic error as a result of drug-laboratory test interactions
29. Reflective testing - A randomized controlled trial in primary care patients.
30. The end of the laboratory developed test as we know it? Recommendations from a national multidisciplinary taskforce of laboratory specialists on the interpretation of the IVDR and its complications.
31. Sigma metrics in laboratory medicine revisited: We are on the right road with the wrong map
32. Global methodology for developmental neurotoxicity testing inhumans and animals early and chronically exposed to chemicalcontaminants
33. Analytical performance specifications in clinical chemistry: the holy grail?
34. The use of error and uncertainty methods in the medical laboratory
35. Could accreditation bodies facilitate the implementation of medical guidelines in laboratories?
36. Impact of interactions between drugs and laboratory test results on diagnostic test interpretation – a systematic review.
37. Total error vs. measurement uncertainty: revolution or evolution?
38. Sigma metric or defects per million opportunities (DPMO): the performance of clinical laboratories should be evaluated by the Sigma metrics at decimal level with DPMOs
39. Why are clinical practice guidelines not followed?
40. Opinion: redefining the role of the physician in laboratory medicine in the context of emerging technologies, personalised medicine and patient autonomy (‘4P medicine’)
41. The quality of laboratory aspects of troponin testing in clinical practice guidelines and consensus documents needs to be improved
42. Clinical impact of direct HDLc and LDLc method bias in hypertriglyceridemia. A simulation study of the EAS-EFLM Collaborative Project Group
43. Critical review of laboratory investigations in clinical practice guidelines: proposals for the description of investigation
44. Accuracy of First and Second Generation Testosterone Assays and Improvement through Sample Extraction
45. How do laboratory specialists advise clinicians concerning the use and interpretation of renal tests?
46. Gross Overestimation of Total Allowable Error Based on Biological Variation
47. Drastic effects of cryoglobulin on blood cell counts, erythrocyte morphology and M-protein analysis
48. Reflective testing in the Netherlands: usefulness to improve the diagnostic and therapeutic process in general practice
49. Do Guidelines for the Diagnosis and Monitoring of Diabetes Mellitus Fulfill the Criteria of Evidence-Based Guideline Development?
50. Postanalytical External Quality Assessment of Blood Glucose and Hemoglobin A1c: An International Survey
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.